FDA Advises on Yasmin Blood Clots Risk: the Threat of Severe Adverse Events from Yasmin Remains

Share Article

On April 10th, 2012 the US FDA ordered revised labels on certain birth-control pills, including Yasmin, to advise of a possibly higher risk of blood clots. Yasmin, approved by the FDA in 2001, is an oral contraceptive that combines estrogen and drospirenone to prevent pregnancy. It is also used to treat premenstrual dysphoric disorder (PMDD) and certain types of moderate acne in women. Yasmin is manufactured by Bayer Healthcare Pharmaceuticals. On February 15th, 2012, North Dakota resident Donna L. Praus filed a lawsuit (case no. 3:2012cv20009) in the Illinois Southern District Court against Bayer Pharmaceuticals claiming that she suffered an alleged deep vein thrombosis (DVT) from taking Yasmin and, its similar sister drug, Yaz. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Yasmin severe adverse events [http://www.attorneyone.com/yasmin-lawsuits/ .

Yasmin severe adverse events threat

Yasmin severe adverse events threat

drospirenone-containing birth control pills, including Yasmin, may be associated with a higher risk for blood clots than other progestin-containing pills.

The media spotlight is often a double-edged sword. No one knows this better than women who suffer from Yasmin Side Effect. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

On April 10th, 2012 the US FDA ordered revised labels on certain birth-control pills, including Yasmin, to advise of a possibly higher risk of blood clots. Yasmin, a popular birth control pill, is designed to prevent ovulation combining estrogen and drospirenone. It was approved by the FDA in 2001 and it is manufactured by Bayer Healthcare Pharmaceuticals. According to the regulators, drospirenone-containing birth control pills, including Yasmin, may be associated with a higher risk for blood clots than other progestin-containing pills.

According to court documents, on February 15th, 2012, North Dakota resident Donna L. Praus filed a lawsuit (case no. 3:2012cv20009) in the Illinois Southern District Court against Bayer Pharmaceuticals claiming that she suffered an alleged deep vein thrombosis from taking Yasmin and its sister drug Yaz. Deep vein thrombosis is a condition in which a blood clot forms in a vein deep in the body and possibly lodging in an artery in the lungs and blocking blood flow.

As of February 1st, 2012, there were about 11,300 lawsuits pending in the United States served upon Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Yasmin and Yaz.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of in case of Yasmin severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse events from Yasmin remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

The 2011 FDA report based on data from more than 835,000 women who took pills containing drospirenone, including Bayer’s Yasmin line of birth-control pills, reveals that these women were 74 percent more likely to suffer blood clots than women on low-estrogen contraceptives.

AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Yasmin at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/4/prweb9380678.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
1-877-230-7343
Email >
Visit website